Downregulation of the NLRC5 transcription factor is associated with decreased expression of target genes such as MHC-I, ß2M, TAP, and immunoproteasome subunits in many cancers, including prostate, lung, uterine, melanoma, and thyroid [43]. This evidence concerns the gene NLRC5 and cancer.